D.E. Shaw & Co
CELG

D.E. Shaw & Co’s Celgene Corp CELG Stock Holding History

D.E. Shaw & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,627,564
Closed -$460M – 4329
2019
Q3 		$460M Buy
4,627,564
+952,261
+26% +$90.5M 0.57% 14
2019
Q2 		$340M Sell
3,675,303
-3,672,266
-50% -$349M 0.42% 31
2019
Q1 		$693M Buy
7,347,569
+258,429
+4% +$22.6M 0.9% 4
2018
Q4 		$454M Buy
7,089,140
+2,779,553
+64% +$205M 0.63% 12
2018
Q3 		$386M Sell
4,309,587
-512,949
-11% -$45.3M 0.46% 22
2018
Q2 		$383M Buy
4,822,536
+536,351
+13% +$44.5M 0.5% 21
2018
Q1 		$382M Buy
4,286,185
+3,529,714
+467% +$339M 0.52% 22
2017
Q4 		$78.9M Sell
756,471
-908,679
-55% -$103M 0.11% 226
2017
Q3 		$243M Sell
1,665,150
-135,794
-8% -$18.5M 0.37% 41
2017
Q2 		$234M Buy
1,800,944
+1,320,338
+275% +$162M 0.39% 35
2017
Q1 		$59.8M Buy
480,606
+225,976
+89% +$27M 0.11% 239
2016
Q4 		$29.5M Sell
254,630
-158,804
-38% -$17.7M 0.05% 475
2016
Q3 		$43.2M Sell
413,434
-54,831
-12% -$5.93M 0.08% 326
2016
Q2 		$46.2M Buy
468,265
+415,477
+787% +$43M 0.09% 282
2016
Q1 		$5.28M Sell
52,788
-1,052,709
-95% -$108M 0.01% 1229
2015
Q4 		$132M Buy
1,105,497
+360,509
+48% +$41.7M 0.2% 113
2015
Q3 		$80.6M Buy
744,988
+454,335
+156% +$56.4M 0.12% 202
2015
Q2 		$33.6M Buy
290,653
+163,005
+128% +$18.6M 0.05% 439
2015
Q1 		$14.7M Buy
127,648
+20,012
+19% +$2.39M 0.02% 745
2014
Q4 		$12M Sell
107,636
-379,708
-78% -$40M 0.02% 990
2014
Q3 		$46.2M Buy
487,344
+37,562
+8% +$3.39M 0.06% 374
2014
Q2 		$38.6M Sell
449,782
-488,800
-52% -$37.2M 0.05% 407
2014
Q1 		$65.5M Buy
938,582
+193,080
+26% +$15.3M 0.09% 233
2013
Q4 		$63M Sell
745,502
-214,736
-22% -$17M 0.09% 241
2013
Q3 		$73.9M Sell
960,238
-1,933,542
-67% -$136M 0.12% 183
2013
Q2 		$169M Buy
+2,893,780
New +$174M 0.32% 43

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

D.E. Shaw & Co's CELG Position: Q4 2019 in Review

D.E. Shaw & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,627,564 shares — an estimated $460M sold.

D.E. Shaw & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $693M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • D.E. Shaw & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,627,564 Celgene Corp shares in Q4 2019, an estimated $460M.
  • D.E. Shaw & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • D.E. Shaw & Co's Celgene Corp position peaked at $693M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.